UMHB Human Performance Lab
Belton, Texas, 76513, United States
Completed
NCT Number: NCT03318731
Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males
This is a randomized, repeated measures and double blind study which measures the effect of fenugreek extract on markers of muscle damage and inflammation in non-resistance trained males. Participants will complete baseline testing and then be randomized into groups. Participants will complete a 2 week, split-body resistance training program. They will then return for testing in which they will complete an overreaching protocol for 5 consecutive days. Measurements will be recorded 24 hrs after the fifth day. Participants will resume the training program for one additional week and return for final measurements.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–45 year
Sex eligibility
Male
Study type
Interventional
Phase
Not applicable
Primary location
About this study
Subjects expressing interest in doing the study will be interviewed in the UMHB Human Performance Lab (HPL) to determine whether they qualify to participate in the study. Upon qualification, participants will be scheduled a familiarization session in which they will be taught how to perform a proper bench press, back squat, deadlift and squat thruster. They will then schedule their first testing session which will include: a body composition analysis via an InBody 770, thigh circumference measurements, joint mobility measurements, a blood draw, strength testing (1RM), and muscular endurance testing (70% 1RM max reps). Participants will then be placed in groups based on fat free mass and assigned their workout program (3days/week) with training loads based on their 1RM values (bench press, back squat, deadlift and squat thruster).
Supplementation protocol: Participants will be randomly assigned into one of three groups and instructed to ingest capsules of either a placebo, or IND03 (fenugreek extract) containing 300mg, or 500mg. They will supplement 1 hour prior to their workout each exercise day as well as during the overreaching week. On "off/rest" days, participants will consume capsules in the morning with breakfast.
After two weeks of training, participants will return to the HPL for follow-up strength testing (1RM), and muscular endurance testing (70% 1RM max reps), then instructed to rest for 48 hours and return to the lab to begin their overreaching protocol. During each of the 5 days, participants undergo the following measurements prior to the exercise protocol: thigh circumference, joint mobility, and questionnaires (WOMAC & VAS). On Day 1 participants will also perform an InBody and blood draw. A blood draw will also be performed on Day 3. They will then consume a standardized snack and begin the overreaching protocol of 8 sets of 10 repetitions for the following 4 exercises: bench press, back squat, deadlift and squat thruster. There will be a 1 minute rest period in between each set and a 2 minute rest in between each exercise. Participants will then fill out a Rate of Perceived Exertion (RPE) immediately after the protocol. Again, they will perform this for 5 consecutive days.
Twenty-four hours after the last overreaching day, participants will return for thigh circumference, joint mobility, questionnaires (WOMAC & VAS), a blood draw, strength testing (1RM), and muscular endurance testing (70% 1RM max reps). They will then be instructed to continue the resistance training program for 1 week. After that period they will return for final measurements of thigh circumference, joint mobility, questionnaires (WOMAC & VAS), a blood draw, strength testing (1RM), and muscular endurance testing (70% 1RM max reps).
Throughout the duration of the study, participants will record their dietary intake via MyFitnessPal.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Subjects will be males between the age of 18-45;
- Subjects will have not been participating in a structured resistance training program in the past 6 months;
- Subjects will be provided written and dated informed consent to participate in the study;
- Subjects will be willing and able to comply with the protocol;
- Subjects will be apparently healthy and free from disease, as determined by a health history questionnaire;
- Subjects will agree to abstain from exercise 48 hours prior to each testing visit;
- Subjects will agree to fast for 10 hours prior to each testing visit;
- Subjects will be agree to refrain from tobacco use, alcohol and/or caffeine consumption and/or smoking 12 hours prior to each testing visit;
- Subjects will agree to refrain from taking any supplement that may interfere with study supplementation for the remainder of the study.
Exclusion criteria
- Subject has taken ergogenic levels of nutritional supplements that may affect muscle mass (e.g., creatine, HMB) or anabolic/catabolic hormone levels (e.g., androstenedione, DHEA, etc.) within 3 months prior to the start of the study;
- Subject is unable to complete blood draws needed at each testing session;
- Subject reports any unusual adverse events associated with this study that in consultation with the supervising physician recommends removal from the study;
- Subject does not complete 90% of resistance training program assigned;
- Subject is unable to complete overreaching protocol during overreaching week;
Treatment and study plan
Sugar Pill
OtherTaken orally in capsule form
Fenugreek Extract, Low Dose
Dietary SupplementTaken orally in capsule form
Fenugreek Extract, High Dose
Dietary SupplementTaken orally in capsule form
Primary outcomes
-
Effect of Fenugreek Extract on Interleukin-1
Time frame: within 26 days
The primary purpose of this investigation is to determine the effectiveness of fenugreek extract on blunting an exercise-induced state of inflammation during a period of high volume and overreaching resistance exercise in young, non-resistance trained males. This will be accomplished by observing blood markers prior to, during and post exercise testing.
-
Effect of Fenugreek Extract on Creatine Kinase
Time frame: within 26 days
The primary purpose of this investigation is to determine if supplementation of fenugreek extract will have a protective effect on muscle damage in response to resistance exercise. This will be accomplished by observing blood markers prior to, during and post exercise testing.
-
Effect of Fenugreek Extract on Interleukin-6
Time frame: within 26 days
The primary purpose of this investigation is to determine the effectiveness of fenugreek extract on blunting an exercise-induced state of inflammation during a period of high volume and overreaching resistance exercise in young, non-resistance trained males. This will be accomplished by observing blood markers prior to, during and post exercise testing.
-
Effect of Fenugreek Extract on Tumor Necrosis Factor Alpha (TNF-α)
Time frame: within 26 days
The primary purpose of this investigation is to determine the effectiveness of fenugreek extract on blunting an exercise-induced state of inflammation during a period of high volume and overreaching resistance exercise in young, non-resistance trained males. This will be accomplished by observing blood markers prior to, during and post exercise testing.
-
Effect of Fenugreek Extract on C-reactive protein
Time frame: within 26 days
The primary purpose of this investigation is to determine the effectiveness of fenugreek extract on blunting an exercise-induced state of inflammation during a period of high volume and overreaching resistance exercise in young, non-resistance trained males. This will be accomplished by observing blood markers prior to, during and post exercise testing.
-
Effect of Fenugreek Extract on 3-methylhistidine
Time frame: within 26 days
The primary purpose of this investigation is to determine if supplementation of fenugreek extract will have a protective effect on muscle damage in response to resistance exercise. This will be accomplished by observing blood markers prior to, during and post exercise testing.
-
Effect of Fenugreek Extract on Lactate Dehydrogenase
Time frame: within 26 days
The primary purpose of this investigation is to determine if supplementation of fenugreek extract will have a protective effect on muscle damage in response to resistance exercise. This will be accomplished by observing blood markers prior to, during and post exercise testing.
Secondary outcomes
-
Effect of Fenugreek Extract on Glucose mg/dL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Urea Nitrogen (BUN) mg/Dl
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Creatinine mg/Dl
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on eGFR Non-Afr. American mL/min/1.73m2
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on eGFR African American mL/min/1.73m2
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on BUN/Creatinine Ratio calculated
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Sodium mmol/L
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Potassium mmol/L
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Chloride mmol/L
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Carbon Dioxide mmol/L
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Calcium mg/Dl
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Protein, Total g/Dl
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Albumin g/dL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Globulin g/Dl
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Albumin/Globulin Ratio calculated
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Bilirubin, Total mg/Dl
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Alkaline Phosphatase U/L
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Aspartate Aminotransferase U/L
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Alanine Aminotransferase U/L
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a comprehensive metabolic panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on White Blood Cell Count thousand/uL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Red Blood Cell Count million/uL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Hemoglobin g/dL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Hematocrit %
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on MCV fL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on MCH pg
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on MCHC g/dL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on RDW %
Time frame: within 26 days
v
-
Effect of Fenugreek Extract on Platelet Count thousand/uL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on MPV fL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Absolute Neutrophils cells/uL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Absolute Lymphocytes cells/uL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Absolute Monocytes cells/uL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Absolute Eosinophils cells/uL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Absolute Basophils cells/uL
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Neutrophils %
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Lymphocytes %
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Monocytes %
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Eosinophils %
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
-
Effect of Fenugreek Extract on Basophils %
Time frame: within 26 days
The secondary purpose is to assess safety of ingestion of the supplement with analysis of a complete blood count panel prior to and after the supplementation period.
Sponsors and collaborators
Lead sponsor
University of Mary Hardin-Baylor
Other
Collaborators
- Indus Biotech Ltd. Pvt.
Registry information
Official study title
Evaluation of the Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation on Healthy Non-resistance Trained Participants
Important dates
- Study start
- 2017
- Primary completion
- 2019
- Study completion
- 2019
- First posted
- Oct 24, 2017
- Registry last updated
- Sep 25, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Completed
The Combined Effects of Cordyceps and Fartlek Training on Muscle Recovery and Bone Health in Soccer Players
NCT07726979
Athletic Performance, Bone Metabolism
Surabaya, Jawa Timur - East Java, Indonesia
View Trial Details
Completed
Effects of Immediate and Delayed Repeated Cold Exposure After Physical Exertion
NCT06813690
Delayed Onset Muscle Soreness (DOMS), Inflammation
Landquart, Switzerland
View Trial Details
Completed
Impact of Powdered Tart Cherries on Recovery From Repeated Sprints
NCT06122038
Inflammation, Muscle Damage
Saint Charles, Missouri, United States
View Trial Details
Completed
Multifaceted Analysis of the Adaptation of Rowers in the Process of Sports Training
NCT06891820
Ferroptosis, Inflammation
Poznan, Poland
View Trial Details